Ethema Health Corporation: 10-Q filed 2022-11-14

Name: Ethema Health Corporation: 10-Q filed 2022-11-14
Creator: Ethema Health Corporation

What Ethema Health Corporation reported in its quarterly report filed 2022-11-14 (fiscal Q3 2022): 40 published measures, 113 facts as tagged in accession 0001903596-22-000804.

This filing

Form: 10-Q (quarterly report)
Filed: 2022-11-14
Fiscal period: fiscal Q3 2022
Accession: 0001903596-22-000804 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Ethema Health Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-09-30	6,728,920	USD
At 2021-12-31	6,554,306	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-09-30	16,149,059	USD
At 2021-12-31	16,009,687	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2022-09-30	-10,695,440	USD
At 2021-12-31	-10,678,257	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2022-09-30	561,083	USD
At 2021-12-31	48,822	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	512,081	USD	92
2022-04-01 to 2022-06-30	-179,614	USD	91
2022-01-01 to 2022-03-31	-164,985	USD	90
2021-07-01 to 2021-09-30	1,528,575	USD	92
2021-04-01 to 2021-06-30	-2,626,438	USD	91
2021-01-01 to 2021-03-31	-2,368,156	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	1,019,112	USD	273
2021-01-01 to 2021-09-30	75,912	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	285,103	USD	273
2021-01-01 to 2021-09-30	31,214	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	1,424,943	USD	92
2022-01-01 to 2022-09-30	3,586,290	USD	273
2021-07-01 to 2021-09-30	866,432	USD	92
2021-01-01 to 2021-09-30	1,053,383	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	393,185	USD	273
2021-01-01 to 2021-09-30	372,199	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	-335,103	USD	273
2021-01-01 to 2021-09-30	-471,427	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-09-30	-44,062,177	USD
At 2021-12-31	-44,103,311	USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	4,276,544,380	shares	92
2022-01-01 to 2022-09-30	4,244,126,798	shares	273
2021-07-01 to 2021-09-30	3,996,020,553	shares	92
2021-01-01 to 2021-09-30	2,474,937,755	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Unit	Days
2022-07-01 to 2022-09-30	USD/shares	92
2022-01-01 to 2022-09-30	USD/shares	273
2021-07-01 to 2021-09-30	USD/shares	92
2021-01-01 to 2021-09-30	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Unit	Days
2022-07-01 to 2022-09-30	USD/shares	92
2022-01-01 to 2022-09-30	USD/shares	273
2021-07-01 to 2021-09-30	USD/shares	92
2021-01-01 to 2021-09-30	USD/shares	273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	44,652	USD	92
2022-01-01 to 2022-09-30	87,615	USD	273
2021-07-01 to 2021-09-30	-18,794	USD	92
2021-01-01 to 2021-09-30	-18,794	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2022-09-30	2,961,837	USD
At 2021-12-31	3,012,663	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	254,982	USD	92
2022-01-01 to 2022-09-30	381,684	USD	273
2021-07-01 to 2021-09-30	118,964	USD	92
2021-01-01 to 2021-09-30	225,285	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit
At 2022-09-30	960,195	USD
At 2021-12-31	271,799	USD
At 2021-09-30	296,042	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit
At 2022-09-30	14,021,707	USD
At 2021-12-31	13,516,802	USD
At 2021-09-30	15,736,863	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2022-09-30	1,342,428	USD
At 2021-12-31	1,610,913	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2022-09-30	287,265	USD
At 2021-12-31	176,011	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	1,169,961	USD	92
2022-01-01 to 2022-09-30	3,204,606	USD	273
2021-07-01 to 2021-09-30	747,468	USD	92
2021-01-01 to 2021-09-30	830,098	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-09-30	3,729,053,805	shares
At 2021-12-31	3,579,053,805	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2022-09-30	561,083	USD
At 2021-12-31	48,822	USD
At 2021-09-30	62,181	USD
At 2020-12-31	90,500	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2022-09-30	22,791,350	USD
At 2021-12-31	22,791,350	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2022-09-30	-9,820,139	USD
At 2022-06-30	-10,137,673	USD
At 2022-03-31	-9,860,462	USD
At 2021-12-31	-9,855,381	USD
At 2021-09-30	-12,003,279	USD
At 2021-06-30	-15,312,711	USD
At 2021-03-31	-14,826,497	USD
At 2020-12-31	-15,026,099	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2022-09-30	1,459,729	USD
At 2021-12-31	1,653,816	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2022-09-30	1,555,504	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2022-09-30	3,684,273	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2022-09-30	722,436	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	556,734	USD	92
2022-01-01 to 2022-09-30	255,098	USD	273
2021-07-01 to 2021-09-30	1,509,781	USD	92
2021-01-01 to 2021-09-30	-3,484,813	USD	273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	167,482	USD	273
2021-01-01 to 2021-09-30	-3,466,019	USD	273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	288,748	USD	92
2022-01-01 to 2022-09-30	-167,182	USD	273
2021-07-01 to 2021-09-30	1,458,764	USD	92
2021-01-01 to 2021-09-30	-3,520,992	USD	273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	458,713	USD	92
2022-01-01 to 2022-09-30	41,135	USD	273
2021-07-01 to 2021-09-30	1,525,766	USD	92
2021-01-01 to 2021-09-30	-3,518,907	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	289,073	USD	92
2022-01-01 to 2022-09-30	760,533	USD	273
2021-07-01 to 2021-09-30	245,546	USD	92
2021-01-01 to 2021-09-30	254,012	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	134,366	USD	273
2021-01-01 to 2021-12-31	101,696	USD	365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	402,851	USD	273
2021-01-01 to 2021-09-30	191,192	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-1,045	USD	92
2022-01-01 to 2022-09-30	10,018	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	158,511	USD	273
2021-01-01 to 2021-09-30	363,251	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	145,833	USD	273
2021-01-01 to 2021-09-30	11,821	USD	273

Inspect the source

Entity: Ethema Health Corporation / CIK 0000792935
Captured: 2026-09-21T17:17:01.527Z
SEC response SHA-256: a4f8fd956c34e77db45dcdd54cc03aee5ac808fb7b9e32559ac9d8a78af1e44e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000792935.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))